Using  FuseBio’s deep understanding of T cell and Natural Killer (NK) cell biology,  their pipeline of multi-functional antibodies leverages the inherent capacity  of NK cells to distinguish between normal and diseased tissue. Their platform  transforms antibodies into danger sensing therapeutics that utilize NK cell  education as an ON/OFF switch to deploy highly potent immune stimulating  cargo that vigorously enhances an immune response to eradicate tumors without  killing a patient’s healthy tissue.